John Varian

Insider Reports History

Location
Fremont, CA
Signature
/s/ Daniel Bagliebter, Power of Attorney for: John Varian
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Varian:

Company Role Class Num Shares Value Price $ Report Date Ownership
SELLAS Life Sciences Group, Inc. Director Common Stock 72,900 $274,789 $3.77 07 Jan 2026 Direct
SELLAS Life Sciences Group, Inc. Director Stock Option (Right to Buy) 18,500 10 Jan 2025 Direct
Acorda Therapeutics, Inc. Director Non-Employee Stock Option 1,200 22 Jun 2023 Direct

Insider Reports Filed by John Varian

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLS SELLAS Life Sciences Group, Inc. 07 Jan 2026 1 $0 4 Director 09 Jan 2026, 16:43
SLS SELLAS Life Sciences Group, Inc. 10 Jan 2025 2 $0 4 Director 14 Jan 2025, 17:30
SLS SELLAS Life Sciences Group, Inc. 22 Jan 2024 2 $0 4 Director 25 Jan 2024, 06:01
ACOR Acorda Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 17:38
SLS SELLAS Life Sciences Group, Inc. 02 Feb 2023 2 $0 4 Director 03 Feb 2023, 16:14
ACOR ACORDA THERAPEUTICS INC 01 Jan 2023 1 $0 4 Director 04 Jan 2023, 06:56
SLS SELLAS Life Sciences Group, Inc. 31 Jan 2022 2 $0 4 Director 01 Feb 2022, 16:06
ACOR ACORDA THERAPEUTICS INC 01 Jan 2022 0 $0 3 Director 05 Jan 2022, 15:25
ACOR ACORDA THERAPEUTICS INC 01 Jan 2022 1 $0 4 Director 04 Jan 2022, 15:22